These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26807494)

  • 21. Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest group.
    Coates LC; Mumtaz A; Helliwell PS; Mease PJ; Callis-Duffin K; Krueger GG; McHugh NJ; Strand V; Gladman DD; FitzGerald O
    J Rheumatol; 2011 Jul; 38(7):1496-501. PubMed ID: 21724722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psoriasis and psoriatic arthritis video project: an update from the GRAPPA 2011 annual meeting.
    Callis Duffin K; Armstrong AW; Mease PJ
    J Rheumatol; 2012 Nov; 39(11):2198-200. PubMed ID: 23118287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
    Mease PJ; Karki C; Palmer JB; Etzel CJ; Kavanaugh A; Ritchlin CT; Malley W; Herrera V; Tran M; Greenberg JD
    Arthritis Care Res (Hoboken); 2017 Nov; 69(11):1692-1699. PubMed ID: 28376239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The assessment of disease activity and outcomes in psoriatic arthritis.
    Kavanaugh A; Cassell S
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S142-7. PubMed ID: 16273798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Composite measures in psoriatic arthritis: GRAPPA 2008.
    Gladman DD; Landewé R; McHugh NJ; Fitzgerald O; Thaci D; Coates L; Mease PJ; Qureshi AA; Krueger GG; Ritchlin CT; Kavanaugh AF; Garg A
    J Rheumatol; 2010 Feb; 37(2):453-61. PubMed ID: 20147481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of training on concordance among rheumatologists and dermatologists in the assessment of patients with psoriasis and psoriatic arthritis.
    Salvarani C; Girolomoni G; Di Lernia V; Gisondi P; Tripepi G; Egan CG; Marchesoni A;
    Semin Arthritis Rheum; 2016 Dec; 46(3):305-311. PubMed ID: 27470190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Recognition and Treatment Heralds Optimal Outcomes: the Benefits of Combined Rheumatology-Dermatology Clinics and Integrative Care of Psoriasis and Psoriatic Arthritis Patients.
    Soleymani T; Reddy SM; Cohen JM; Neimann AL
    Curr Rheumatol Rep; 2017 Nov; 20(1):1. PubMed ID: 29185062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psoriatic arthritis - update on pathophysiology, assessment, and management.
    Mease PJ
    Bull NYU Hosp Jt Dis; 2010; 68(3):191-8. PubMed ID: 20969551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psoriasis and psoriatic arthritis video project: an update from the 2010 GRAPPA annual meeting.
    Woodcock JL; Mease PJ; Callis Duffin K
    J Rheumatol; 2012 Feb; 39(2):421-2. PubMed ID: 22298271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psoriatic arthritis assessment tools in clinical trials.
    Mease PJ; Antoni CE; Gladman DD; Taylor WJ
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii49-54. PubMed ID: 15708937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benchmarking Care in Psoriatic Arthritis - The QUANTUM Report: A Report from the GRAPPA 2016 Annual Meeting.
    Favier G; Gladman DD; Merola JF; Armstrong AW; Boehncke WH; Helliwell PS
    J Rheumatol; 2017 May; 44(5):674-678. PubMed ID: 28461523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidisciplinary dermatology-rheumatology management for patients with moderate-to-severe psoriasis and psoriatic arthritis: a systematic review.
    Cobo-Ibáñez T; Villaverde V; Seoane-Mato D; Muñoz-Fernández S; Guerra M; Del Campo PD; Cañete JD
    Rheumatol Int; 2016 Feb; 36(2):221-9. PubMed ID: 26438388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP).
    Duvetorp A; Østergaard M; Skov L; Seifert O; Tveit KS; Danielsen K; Iversen L
    Arch Dermatol Res; 2019 Jul; 311(5):351-360. PubMed ID: 30868221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Nail Psoriasis With Disease Activity Measures and Impact in Psoriatic Arthritis: Data From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
    Mease PJ; Liu M; Rebello S; McLean RR; Dube B; Glynn M; Hur P; Ogdie A
    J Rheumatol; 2021 Apr; 48(4):520-526. PubMed ID: 33060307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis.
    Chandran V; Gottlieb A; Cook RJ; Duffin KC; Garg A; Helliwell P; Kavanaugh A; Krueger GG; Langley RG; Lynde C; McHugh N; Mease P; Olivieri I; Rahman P; Rosen CF; Salvarani C; Thaci D; Toloza SM; Wong MY; Zhou QM; Gladman DD
    Arthritis Rheum; 2009 Sep; 61(9):1235-42. PubMed ID: 19714610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psoriasis and psoriatic arthritis video project: an update from the 2012 GRAPPA annual meeting.
    Callis Duffin K; Armstrong AW; Mease PJ
    J Rheumatol; 2013 Aug; 40(8):1455-6. PubMed ID: 23908546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of disease activity in psoriatic arthritis.
    Helliwell PS
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S44-7. PubMed ID: 26471097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatology.
    Gottlieb AB; Levin AA; Armstrong AW; Abernethy A; Duffin KC; Bhushan R; Garg A; Merola JF; Maccarone M; Christensen R
    J Am Acad Dermatol; 2015 Feb; 72(2):345-8. PubMed ID: 25486914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials.
    Perez-Chada LM; Gottlieb AB; Cohen J; Mease P; Duffin KC; Garg A; Latella J; Armstrong AW; Ogdie A; Merola JF
    J Am Acad Dermatol; 2020 Jan; 82(1):54-61. PubMed ID: 31163240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel methods of measuring clinical outcomes from psoriasis and psoriatic arthritis clinical trials.
    Villacorta R; Hay JW; Messali A
    Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):545-58. PubMed ID: 24820676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.